Eli Lilly (NYSE:LLY) has completed its acquisition
Post# of 148179
(Total Views: 476)
Posted On: 02/24/2020 7:14:38 AM
Eli Lilly (NYSE:LLY) has completed its acquisition of 26,043,820 common shares of Loxo Oncology (NASDAQ:LOXO) at $235 per share for a total of ~$6.12B, representing an 84.6% stake.
_______________________
Or about $14 per share of CYDY (430 mil/26mil)
_______________________
Or about $14 per share of CYDY (430 mil/26mil)
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼